Journal of Vaccines & Vaccination

Brazilian public HPV vaccination program: First two years of experience

6^th Euro Global Summit and Expo on Vaccines & Vaccination

August 17-19, 2015 Birmingham, UK

Leandro Santos de Araujo Resende

Scientific Tracks Abstracts: J Vaccines Vaccin

Abstract:

Introduction: Cervical cancer is the fourth cause of death in women worldwide. In Brazil, 17,540 women were diagnosed in
2012 with the disease. The screening program for cervical cancer is not organized and cytology (Pap smear) is performed for
women aged 25-64 years. The use of quadrivalent HPV vaccine started in 2013 and the first city to adopt the program was
Brasilia – DF.
Objective: To provide background data for strengthening cervical cancer prevention in Brazil. Describe the importance of a
large populational public vaccine program for prevent cervical cancer in the next decades.
Methods: Objective analysis of the record of women who received the HPV quadrivalent vaccine in Brasilia - DF in the years
2013-2014. The data was provided for the District Board of Health.
Results: Brazilian HPV vaccination program used quadrivalent vaccine and enroll women aged 9-13 years. It was performed
at public schools with 3 doses (0-2-6 months), it was funded by the Ministry of Health with no extra cost to the population.
62.854 women were eligible for the vaccinein Brasilia and the coverage of first dose was 94%; 94.04% second dose and 88.86%
the last dose.
Conclusion: Our data indicate that the vaccination of young women may be the right strategy for prevention of pre-invasive
and invasive squamous lesions due to reduce the prevalence and persistent HPV infection. However, it needs an organized
vaccination program, with the appropriate target population coverage and to maintain a high rate of adherence of these women.

Biography :

Leandro Santos de Araujo Resende has completed his Masters’s degree from State University of Campinas – UNICAMP, Campinas, SP, Brazil. He is currently
responsible for colposcopy service and is the emergency manager of HRAN (Regional Hospital) in Brasilia DF. He participates in the Unicamp research group, with
Prof. PhD. Sophie Derchain.